Literature DB >> 8405264

In vivo electrochemical measurements of exogenous dopamine clearance in normal and neonatal 6-hydroxydopamine-treated rat striatum.

J Luthman1, M N Friedemann, B J Hoffer, G A Gerhardt.   

Abstract

The regulation of extracellular dopamine (DA) levels was studied in rat striatum after neonatal dopamine lesions and enhanced serotonin (5-HT) fiber ingrowth, induced with 6-hydroxydopamine (6-OHDA). We used rapid in vivo chronoamperometry combined with local DA applications. DA was pressure ejected in doses of 5 to 100 pmol at a distance of approximately 300 microns from the recording electrode, using single- or multibarrel glass micropipettes. Almost twice as much DA had to be applied in control rat dorsal and ventral striatum to obtain signals comparable to those recorded in the neonatal 6-OHDA-treated animals. In addition, in the dorsal striatum, the later portions of the DA clearance signals were significantly prolonged in the 6-OHDA group. Some clearance decay times in ventral striatum were also significantly prolonged in the neonatal 6-OHDA-treated rats. Concomitant application of the DA uptake inhibitor, nomifensine, in conjunction with the DA ejections, produced signal characteristics in the control striatum that were similar to those seen in the neonatal 6-OHDA-treated striatum. Taken together, these data support the hypothesis that a major component of the clearance of extracellular DA is dependent on intact terminals with high-affinity DA uptake, and that loss of DA afferents from neonatal 6-OHDA treatment results in a slowed clearance time of extracellular DA which is not apparently compensated by the enhanced 5-HT fiber ingrowth.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405264     DOI: 10.1006/exnr.1993.1127

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  Differential effects of amphetamine isomers on dopamine release in the rat striatum and nucleus accumbens core.

Authors:  Paul E A Glaser; Theresa C Thomas; B Matthew Joyce; F Xavier Castellanos; Greg A Gerhardt
Journal:  Psychopharmacology (Berl)       Date:  2004-09-30       Impact factor: 4.530

2.  In vivo electrochemical measurements of serotonin clearance in rat striatum: effects of neonatal 6-hydroxydopamine-induced serotonin hyperinnervation and serotonin uptake inhibitors.

Authors:  J Luthman; M N Friedemann; B J Hoffer; G A Gerhardt
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Interaction between diffusion and Michaelis-Menten uptake of dopamine after iontophoresis in striatum.

Authors:  C Nicholson
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

4.  Adderall produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers.

Authors:  B Matthew Joyce; Paul E A Glaser; Greg A Gerhardt
Journal:  Psychopharmacology (Berl)       Date:  2006-10-10       Impact factor: 4.530

Review 5.  Presynaptic control of serotonin on striatal dopamine function.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Psychopharmacology (Berl)       Date:  2010-10-16       Impact factor: 4.530

6.  Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: II. Effects on extracellular monoamine, acetylcholine and adenosine levels monitored with in vivo microdialysis.

Authors:  M Herrera-Marschitz; J Luthman; S Ferré
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

7.  Decreased dopamine D4 receptor expression increases extracellular glutamate and alters its regulation in mouse striatum.

Authors:  Theresa Currier Thomas; David K Grandy; Greg A Gerhardt; Paul E A Glaser
Journal:  Neuropsychopharmacology       Date:  2008-06-04       Impact factor: 7.853

8.  Dopamine D4 receptor knockout mice exhibit neurochemical changes consistent with decreased dopamine release.

Authors:  Theresa Currier Thomas; Paul J Kruzich; B Matthew Joyce; C R Gash; Katherine Suchland; Stewart P Surgener; Erin C Rutherford; David K Grandy; Greg A Gerhardt; Paul E A Glaser
Journal:  J Neurosci Methods       Date:  2007-03-18       Impact factor: 2.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.